The role of Tbx2 in pancreatic cancers and its regulation by Wnt/ β-catenin signaling

Chinese-German Journal of Clinical Oncology

Volumn 7, Issue 7, 2008, Pages 404-409

  Chen, Ping ^a   Tian, Dean ^b   Liu, Mei ^b  

^a CHONGQING THREE GORGES UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

catenin; Pancreatic cancer; Tbx2

Indexed keywords

EID: 48749133228     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/s10330-008-0054-7     Document Type: Article

References (15)

1. Zheng ZT, ed. Gastroenterology. 2nd ed. Beijing: People's Medical Publishing House, 2000. 1414-1429.
2. Rowley M, Grothey E, Couch FJ. The role of Tbx2 and Tbx3 in mammary development and tumorigenesis. J Mammary Gland Biol Neoplasia, 2004, 9: 109-118.
3. Minguillon C, Logan M. The comparative genomics of T-box genes. Brief Funct Genomic Proteomic, 2003, 2: 224-233.
4. Vance KW, Carreira S, Brosch G, et al. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res, 2005, 65: 2260-2268.
5. Sinclair CS, Adem C, Naderi A, et al. TBX2 is preferentially amplified in BRCA1-and BRCA2-related breast tumors. Cancer Res, 2002, 62: 3587-3591.
6. Mahlamäki EH, Bärlund M, Tanner M, et al. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer, 2002, 35: 353-358.
7. Bilican B, Goding CR. Cell cycle regulation of the T-box transcription factor tbx2. Exp Cell Res, 2006, 312: 2358-2366.
8. Marsh KL, Varley JM. Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry. Br J Cancer, 1998, 77: 1460-1468.
9. Bornman PC, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. Pancreatic tumours. BMJ, 2001, 322: 721-723.
10. Wu G, Sinclair C, Hinson S, et al. Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors. Cancer Res, 2001, 61: 4951-4955.
11. Law DJ, Gebuhr T, Garvey N, et al. Identification, characterization, and localization to chromosome 17q21-22 of the human TBX2 homolog, member of a conserved developmental gene family. Mamm Genome, 1995, 6: 793-797.
12. Guo-Chang F, Chu-Tse W. Transfer of p14ARF gene in drug-resistant human breast cancer MCF-7/Adr cells inhibits proliferation and reduces doxorubicin resistance. Cancer Lett, 2000, 158: 203-210.
13. Cui J, Zhou XD, Shen YK. Wnt signaling and tumors. Foreign Med Sci Cancer Sec (Chinese), 2000, 27: 138-140.
14. Tulac S, Nayak NR, Kao LC, et al. Identification, characterization, and regulation of the canonical Wnt signaling pathway in human endometrium. J Clin Endocrin Metab, 2003, 88: 3860-3866.
15. Miller JR. Wnt signaling transduction. In Alison Med. The cancer handbook. London Nature Publishing Group, 2002. 195-208.